[1]
de Portu, S. et al. 2008. Cost-utility analysis of abatacept in rheumatoid arthritis in Italy. Farmeconomia. Health economics and therapeutic pathways. 9, 1 (Mar. 2008), 19–26. DOI:https://doi.org/10.7175/fe.v9i1.212.